Articles · Sexual Health

GSM: Vaginal Symptoms That Get Worse Over Time

Why genitourinary syndrome of menopause progresses without treatment, and what actually works.

7 min read · Published May 30, 2026 · Updated August 28, 2026

Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.

GSM: Vaginal Symptoms That Get Worse Over Time

Hot flashes get most of the attention in menopause. A second group of symptoms affects more women, lasts longer, and usually gets worse rather than better over time. It has a name: genitourinary syndrome of menopause, or GSM.

The term was updated in 2014 from “vulvovaginal atrophy” to reflect how broad it really is. GSM covers genital, urinary, and sexual symptoms that all trace back to one cause: falling estrogen in tissues that depend on it heavily.[1]

How Common Is It?

Estimates vary because studies measure different symptoms with different tools. Across the research, somewhere between 27% and 84% of postmenopausal women are affected.[2] Even at the low end, it is one of the most common conditions of menopause.

The more striking numbers are about how rarely it comes up. An estimated 60% of women with GSM never raise it with a healthcare provider, and most assume the symptoms are a normal, fixed part of ageing. Studies show only 7% of providers ask about these symptoms.[3]

What GSM Actually Involves

GSM is not just vaginal dryness. It spans three overlapping areas.[1][4]

Genital symptoms: dryness, burning, irritation, and less lubrication. The vaginal walls thin and lose stretch as estrogen-dependent tissue breaks down. Vaginal pH rises as the protective lactobacilli, which need estrogen-driven glycogen, decline, and that raises the risk of infection.

Sexual symptoms: painful sex (dyspareunia), spotting after sex, and reduced sensitivity. These follow directly from the tissue changes. Friction that a well-estrogenised vagina handles easily causes pain and tiny tears in thinned tissue.

Urinary symptoms: urgency, frequency, waking at night to urinate, pain on urination, and repeated urinary tract infections. The urethra and the base of the bladder are estrogen-sensitive too. As local estrogen falls, the urethral lining thins, urgency rises, and the defences against infection weaken.

These three areas often occur together and feed each other.

Why GSM Is Different From Hot Flashes

Hot flashes usually peak in perimenopause and early postmenopause, then fade for most women. GSM goes the other way.

Both how common it is and how severe it gets rise with time after menopause.[5] Without treatment, the tissue keeps thinning as it goes without estrogen. A woman five years postmenopausal usually has worse GSM than one a year out, if nothing is done.

This is why “it will pass” does not apply here. Untreated, GSM is a progressive condition.

Treatment Options

Treatment runs from non-hormonal over-the-counter products to prescription local hormone therapy. The right choice depends on how severe the symptoms are, personal preference, and any history of a hormone-sensitive cancer.

Non-hormonal first-line options

For mild to moderate symptoms, two types of non-prescription product have clinical support.[6]

Vaginal moisturisers are used regularly, typically two to three times a week, and work by keeping the tissue hydrated and the pH normal over time. They are not just for use during sex. Regular use maintains the vaginal environment better than applying them only when needed. Look for hyaluronic acid, polycarbophil, or hypromellose as the active ingredient.

Lubricants give immediate relief during sex but do not treat the tissue changes. Water-based lubricants work with condoms and sex toys. Silicone-based ones last longer and suit penetrative sex better. Oil-based lubricants are not safe with latex condoms.

Hyaluronic acid vaginal products have short-term effects comparable to topical estrogen for GSM symptoms, which makes them a real option for women who cannot or would rather not use hormones.[7]

Local (vaginal) estrogen therapy

Local estrogen is applied straight to the vaginal tissue in small doses as a cream, pessary, or ring. Because it acts locally rather than through the whole body, very little is absorbed elsewhere. Several guidelines, including those from NAMS and NICE, consider local vaginal estrogen the most effective treatment for moderate to severe GSM.[3][8]

For most healthy women, local vaginal estrogen does not carry the same risk profile as systemic HRT. It does not raise estrogen levels in the blood and does not need a progestogen alongside it, unlike systemic HRT in women with a womb.

For women with a history of hormone-receptor-positive breast cancer, local estrogen is a complex area and should be discussed individually with an oncologist.

Ospemifene

Ospemifene is a selective estrogen receptor modulator (SERM) taken as a tablet. It acts like estrogen on vaginal tissue while having neutral or opposite effects at the breast. It is approved for moderate to severe painful sex due to GSM and is a non-hormonal prescription option for women who want or need oral treatment.[4]

Vaginal DHEA (prasterone)

Prasterone is a precursor hormone that converts locally in vaginal tissue into both estrogens and androgens. Available as a vaginal insert, it has evidence for improving painful sex, dryness, and urinary symptoms without meaningfully raising hormone levels in the blood.[4]

Talking to Your Doctor

Most women with GSM are not asked about it and do not bring it up. If vaginal dryness, pain during sex, more urinary urgency, or repeated UTIs are part of your experience, these are treatable symptoms and a legitimate reason for a clinical conversation.

Questions worth asking:

GSM has a clear physical cause and several treatment paths.


References

[1] Portman, D. J., Gass, M. L. S. (2014). Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause, 21(10), 1063-1068. Cited in: Gandhi, J., et al. (2016). Genitourinary syndrome of menopause: An overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. https://www.ncbi.nlm.nih.gov/books/NBK559297/

[2] Palacios, S., Combalia, J., Emsellem, C., Garrido, N., Khorsandi, D. (2023). Genitourinary syndrome of menopause: A narrative review focusing on its effects on the sexual health and quality of life of women. Nutrients, 15, 823. https://pmc.ncbi.nlm.nih.gov/articles/PMC10692865/

[3] The Menopause Society (NAMS). (2020). Position Statement on Genitourinary Syndrome of Menopause. https://menopause.org/wp-content/uploads/default-document-library/2020-gsm-ps.pdf

[4] Alvisi, S., Gava, G., Orsili, I., et al. (2020). Vaginal health in menopausal women. Medicina, 56(9), 491. https://pmc.ncbi.nlm.nih.gov/articles/PMC7558330/. See also: StatPearls review https://www.ncbi.nlm.nih.gov/books/NBK559297/

[5] Nappi, R. E., Martini, E., Cucinella, L., et al. (2022). Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women. Frontiers in Endocrinology, 12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7212735/

[6] Sarmento, A. C. A., Costa, A. P. F., Vieira-Baptista, P., et al. (2022). Use of moisturizers and lubricants for vulvovaginal atrophy. International Journal of Environmental Research and Public Health, 19(9). https://pmc.ncbi.nlm.nih.gov/articles/PMC9580673/

[7] Jokar, A., Davari, T., Asadi, N., Ahmadi, F., Foruhari, S. (2016). Comparison of the hyaluronic acid vaginal cream and conjugated estrogen used in treatment of vaginal atrophy of menopause women. Iranian Journal of Nursing and Midwifery Research, 21(1). Cited in: https://pmc.ncbi.nlm.nih.gov/articles/PMC9408661/

[8] NICE Guideline NG23. (2023). Menopause: Diagnosis and Management. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng23

Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.